AusPAR: Talimogene laherparepvec

Australian Public Assessment Report

AusPAR

AusPAR: Talimogene laherparepvec [PDF, 1.98 MB]

AusPAR: Talimogene laherparepvec [Word, 3.53 MB]

Attachment: Product Information: Talimogene laherparepvec [PDF, 397.72 KB]

Attachment: Product Information: Talimogene laherparepvec [Word, 533.69 KB]

Attachment: Extract from Clinical Evaluation Report: Talimogene laherparepvec [PDF, 1.86 MB]

Attachment: Extract from the Clinical Evaluation Report: Talimogene Laherparepvec [Word, 3.73 MB]

Device/Product Name

Imlygic

Active ingredients

Talimogene laherparepvec

AusPAR Date

31 May 2016

Published

6 June 2016

Submission Number

PM-2014-03464-1-4

Submission Type

New biological entity

Decision

Approved